Health Care -

Your samples

  • No items in the basket
  • Add more products View basket View products to order samples

Remove from basket

Are you sure you want to remove from the sample cart?

Your Language

English Português Español
Health Care
Health Care
  • Products and Applications
    • Product Finder
    • Dietary Supplements  
    • Eye, Ear & Nose  
    • Vaccine Adjuvants  
    • Omega 3 API  
    • Oral  
    • Parenteral  
    • Rectal and Vaginal  
    • Topical  
    • Veterinary Health  
      • Formulation Finder

        Formulation Finder

        Browse our range of fully developed formulations for inspiration and guidance.
        View
  • Technical Library
    • Formulation Finder
    • Brochures  
    • Datasheets and MSDS  
    • FDA IID Sheets  
    • Vaccine Adjuvants – Certificates of GMP Compliance  
    • Excipient Information Package  
    • Presentations  
    • Product Overview Sheets  
    • Videos  
    • Webinars  
      • Product Finder

        Product Finder

        Find a product to suit your needs from our high purity excipients portfolio.
        Product Finder
  • Discovery Zone
    • Product Effects
      • SEDDS and SMEDDS  
      • Increased Vaccine Efficacy  
      • Solubilisers and Emulsifiers  
      • Solvents  
      • Penetration Enhancers  
      • Controlled Release  
      • Skin Barrier Repair with Lanolin  
      • Film Forming Polymers  
    • Chemical Industry Helping to Fight COVID-19  
    • Our Technologies
      • Super Refined Excipients  
      • API grade Omega 3  
      • Vaccine Adjuvant Technology  
      • New Drug Delivery Technology – ProSilic®  
    • Emulsifier Selector  
    • Pharmaceutical Solubility Guide  
    • Veterinary Solubility Guide  
    • Leaders in Regulatory Excellence  
    • How We Can Help  
    • Events Calendar
      • Smarter Innovation Through Quality  
      • DDF Summit - March 2021  
      • Product Effects

        Product Effects

        View our product offerings.
        View
  • News
    • Business News  
    • Events  
    • Innovation  
    • Sustainability  
    • Trends  
      • Events Calendar

        Events Calendar

        We will be present at key industry events taking place over the year around the globe.
        Events
  • Contact  
  1. Home
  2. News
  3. 2020
  4. 11
  5. Contract for innovative delivery system for COVID-19 vaccine

News categories

  • Business News
  • Events
  • Innovation
  • Sustainability
  • Trends

Contract for innovative delivery system for COVID-19 vaccine

Innovation, Business News
10 Nov 2020
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. The person responsible for making this announcement is David Bishop, Director of Investor Relations.

Croda International Plc (“Croda” or “the Group”), the speciality chemical company that uses smart science to create high performance ingredients and technologies that improve lives, today announces that it has recently entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate. The contract with Pfizer runs for five years and awards Croda an initial supply contract for four component excipients used in the production of the vaccine candidate for the first three years of the contract. Demand remains subject to relevant approvals.

Croda’s recently acquired subsidiary, Avanti Polar Lipids, Inc. (“Avanti”), specialises in the development and production of high-purity lipids, to produce research and clinical trial quantities of excipients in order to stabilise formulations and enable delivery into the body by parenteral mechanism (injection) for drug and vaccine applications. Croda’s existing health care business has a 20-year track record in developing IP-rich, innovative technologies for drug delivery systems for the pharmaceutical industry and has been working with Avanti, prior to and since its acquisition by Croda, to refine the complex processes involved in achieving the volumes of high-purity excipients required by its pharmaceutical customers. Croda has reprioritised investment, resources and other projects across the Group over the last few months to focus on the delivery of this project.

Commenting on the new contract, Steve Foots, Chief Executive Officer, said:  

“I’m very proud of Croda’s involvement in the battle to fight the most significant pandemic that we have seen in a generation. The application of our innovative capabilities is testament to the strong progress we have made to create industry-leading drug delivery systems, focused on developing speciality excipients and adjuvants to improve the effectiveness and stability of complex drug actives and vaccines. It is another example of why our Purpose - Smart Science to Improve Lives – sits at the heart of our strategy and will continue to drive our priorities and ambitions in the years ahead.”
For more information, please use our online contact form.

Share this page

  • Click to print this page
  • LinkedIn
  • Facebook
  • Click to share this page on twitter
  • Click to email
    Email Address
    Are you human?
Product Finder Search our product database
MSDS Search for a material safety datasheet
Contact Us Contact your local office

Health Care

We at Croda contribute to a healthier world by offering ingredients and formulation expertise which help our pharmaceutical customers get the best performance from their active ingredients.

Follow us on social media
  • Health Care on LinkedIn

Corporate

  • Products and markets
  • Where we operate
  • Current vacancies
  • Annual Report
  • Sustainability Reports
  • GRI Report
Visit our corporate site
© 2021 Croda International Plc
© 2021 Croda International Plc | Terms and Conditions | Privacy Policy | Accessibility statement

About cookies on this site
By continuing to use this website, you agree to the use of cookies. You can find out more details in our Privacy policy.